The global Albumin (as Excipient) market size was valued at USD 4466.1 million in 2022 and is forecast to a readjusted size of USD 6643.7 million by 2029 with a CAGR of 5.8% during review period.
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019. By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.
This report is a detailed and comprehensive analysis for global Albumin (as Excipient) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Albumin (as Excipient) market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Albumin (as Excipient) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Albumin (as Excipient) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Albumin (as Excipient) market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Albumin (as Excipient)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Albumin (as Excipient) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
Human Serum Albumin
Recombinant Albumin
Cell Culture Media
Medical Supplements
Therapeutics
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Strengths:
- Albumin is a widely recognized and effective excipient in drug formulation, enhancing the stability and bioavailability of drugs.
- Strong market demand driven by the increasing use of biologics and protein-based therapies.
Weaknesses:
- High cost of production due to complex manufacturing processes.
- Limited availability from animal-derived sources may face regulatory and ethical challenges.
Opportunities:
- Advancements in recombinant DNA technology may reduce production costs and supply limitations.
- Growing focus on personalized medicine and biologics presents opportunities for expanding albumin-based formulations.
Threats:
- Regulatory hurdles in the approval of albumin-based excipients for new drug formulations.
- Competition from alternative excipients that may offer lower costs or better stability for specific formulations.
Political:
- Regulatory scrutiny on animal-derived products may impact the approval process for albumin-based excipients.
- Government policies promoting biologics and protein-based therapies can drive the demand for albumin in drug formulations.
Economic:
- High production costs of albumin may limit its adoption in price-sensitive markets.
- The growing biologics market provides an economic opportunity for albumin as an essential excipient in advanced drug formulations.
Social:
- Increasing demand for personalized medicine fuels the need for excipients like albumin to support protein-based therapies.
- Public concern over the use of animal-derived ingredients could influence consumer and healthcare provider preferences.
Technological:
- Advancements in recombinant DNA technology could enable more cost-effective and scalable production of albumin.
- Innovations in drug delivery systems may increase the use of albumin as a stabilizing excipient in novel formulations.
Environmental:
- The environmental impact of sourcing albumin from animal products raises sustainability concerns among stakeholders.
- Biotechnological approaches to produce albumin from non-animal sources may address environmental and ethical challenges.
Legal:
- Stringent regulations surrounding the use of animal-derived ingredients in pharmaceuticals could create barriers for albumin-based excipients.
- Intellectual property rights on recombinant albumin technologies may influence market dynamics and competition.
Suppliers:
- Biopharmaceutical manufacturers providing albumin from animal and recombinant sources.
- Technology companies that supply advanced production systems for recombinant albumin.
Inputs:
- Raw materials like human or animal plasma, or genetically engineered cells for recombinant albumin production.
- Advanced biotechnological equipment and facilities for albumin extraction and purification.
Process:
- Purification and formulation of albumin as an excipient for drug delivery systems.
- Quality control and regulatory compliance processes for albumin-based excipient products.
Outputs:
- Albumin-based excipients for drug formulation, enhancing drug stability and efficacy.
- Recombinant albumin formulations that meet regulatory standards and are ready for pharmaceutical use.
Customers:
- Pharmaceutical companies developing biologics and protein-based therapies.
- Healthcare providers and regulatory bodies requiring safe, effective excipient formulations for drug approval.
Threat of New Entrants:
- High barriers to entry due to the complex and expensive manufacturing process for albumin.
- Regulatory challenges in obtaining approval for albumin as an excipient may deter new market entrants.
Bargaining Power of Suppliers:
- Limited number of suppliers for high-quality albumin, especially recombinant sources, increasing supplier power.
- Dependence on animal-derived sources for albumin may give suppliers more control over pricing and availability.
Bargaining Power of Buyers:
- Pharmaceutical companies have significant bargaining power due to the availability of alternative excipients and the ability to negotiate pricing.
- However, the growing demand for biologics and protein-based drugs could slightly reduce buyer power in the albumin market.
Threat of Substitutes:
- Other excipients, such as polysorbates and cyclodextrins, can be used as alternatives to albumin, posing a moderate threat.
- Technological advancements in drug formulation could lead to the development of more effective substitutes, reducing the reliance on albumin.
Industry Rivalry:
- Intense competition among established biopharmaceutical companies for market share in the biologics and excipient sectors.
- Rivalry could increase as recombinant albumin technologies evolve, and new players enter the market with cost-effective production methods.
Raw Material Sourcing:
- Sourcing albumin from human plasma or animal-derived materials involves complex ethical and regulatory considerations, impacting availability and cost.
- Increasing use of recombinant DNA technology offers an alternative to animal-derived sources, enhancing supply chain reliability.
Manufacturing & Production:
- Production of high-quality albumin requires advanced biotechnological processes, which are resource-intensive and require skilled labor and infrastructure.
- Technological advancements in recombinant albumin production may reduce manufacturing costs and improve scalability, but investment in R&D is essential.
Processing & Refining:
- The refining process for albumin includes purification, which is crucial for ensuring high-quality standards and regulatory compliance.
- Advancements in purification technologies, such as chromatographic techniques, help improve yield and reduce contamination risks during albumin processing.
Packaging & Distribution:
- The need for specialized packaging solutions, such as freeze-dried or lyophilized forms, ensures the stability of albumin during storage and transportation.
- Efficient distribution channels are essential to ensure that albumin excipients reach pharmaceutical manufacturers, especially given the global nature of the biologics market.
Pharmaceutical Application:
- Albumin as an excipient plays a critical role in enhancing the stability and bioavailability of biologic drugs and protein-based therapies.
- The increasing adoption of biologics in the healthcare industry is driving the demand for albumin as an excipient, particularly in injectable drug formulations.
Regulatory & Market Adoption:
- Stringent regulatory requirements for drug formulations using albumin ensure product safety but may slow down the market adoption rate.
- Pharmaceutical companies increasingly prioritize albumin's compatibility and effectiveness in drug delivery, contributing to its growing presence in drug development pipelines.
Chapter 1, to describe Albumin (as Excipient) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Albumin (as Excipient), with price, sales, revenue and global market share of Albumin (as Excipient) from 2018 to 2023.
Chapter 3, the Albumin (as Excipient) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Albumin (as Excipient) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Albumin (as Excipient) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Albumin (as Excipient).
Chapter 14 and 15, to describe Albumin (as Excipient) sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Albumin (as Excipient)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Albumin (as Excipient) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Human Serum Albumin
1.3.3 Recombinant Albumin
1.4 Market Analysis by Application
1.4.1 Overview: Global Albumin (as Excipient) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cell Culture Media
1.4.3 Medical Supplements
1.4.4 Therapeutics
1.5 Global Albumin (as Excipient) Market Size & Forecast
1.5.1 Global Albumin (as Excipient) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Albumin (as Excipient) Sales Quantity (2018-2029)
1.5.3 Global Albumin (as Excipient) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 CSL
2.1.1 CSL Details
2.1.2 CSL Major Business
2.1.3 CSL Albumin (as Excipient) Product and Services
2.1.4 CSL Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 CSL Recent Developments/Updates
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Albumin (as Excipient) Product and Services
2.2.4 Grifols Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Grifols Recent Developments/Updates
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business
2.3.3 Takeda Albumin (as Excipient) Product and Services
2.3.4 Takeda Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Takeda Recent Developments/Updates
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Albumin (as Excipient) Product and Services
2.4.4 Octapharma Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Octapharma Recent Developments/Updates
2.5 Hualan Bio
2.5.1 Hualan Bio Details
2.5.2 Hualan Bio Major Business
2.5.3 Hualan Bio Albumin (as Excipient) Product and Services
2.5.4 Hualan Bio Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hualan Bio Recent Developments/Updates
2.6 CBPO
2.6.1 CBPO Details
2.6.2 CBPO Major Business
2.6.3 CBPO Albumin (as Excipient) Product and Services
2.6.4 CBPO Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 CBPO Recent Developments/Updates
2.7 Shanghai RAAS
2.7.1 Shanghai RAAS Details
2.7.2 Shanghai RAAS Major Business
2.7.3 Shanghai RAAS Albumin (as Excipient) Product and Services
2.7.4 Shanghai RAAS Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Shanghai RAAS Recent Developments/Updates
2.8 Kedrion
2.8.1 Kedrion Details
2.8.2 Kedrion Major Business
2.8.3 Kedrion Albumin (as Excipient) Product and Services
2.8.4 Kedrion Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Kedrion Recent Developments/Updates
2.9 LFB Group
2.9.1 LFB Group Details
2.9.2 LFB Group Major Business
2.9.3 LFB Group Albumin (as Excipient) Product and Services
2.9.4 LFB Group Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 LFB Group Recent Developments/Updates
2.10 Albumedix
2.10.1 Albumedix Details
2.10.2 Albumedix Major Business
2.10.3 Albumedix Albumin (as Excipient) Product and Services
2.10.4 Albumedix Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Albumedix Recent Developments/Updates
2.11 Biotest
2.11.1 Biotest Details
2.11.2 Biotest Major Business
2.11.3 Biotest Albumin (as Excipient) Product and Services
2.11.4 Biotest Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Biotest Recent Developments/Updates
2.12 Merck
2.12.1 Merck Details
2.12.2 Merck Major Business
2.12.3 Merck Albumin (as Excipient) Product and Services
2.12.4 Merck Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Merck Recent Developments/Updates
2.13 Ventria (InVitria)
2.13.1 Ventria (InVitria) Details
2.13.2 Ventria (InVitria) Major Business
2.13.3 Ventria (InVitria) Albumin (as Excipient) Product and Services
2.13.4 Ventria (InVitria) Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Ventria (InVitria) Recent Developments/Updates
2.14 HiMedia
2.14.1 HiMedia Details
2.14.2 HiMedia Major Business
2.14.3 HiMedia Albumin (as Excipient) Product and Services
2.14.4 HiMedia Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 HiMedia Recent Developments/Updates
3 Competitive Environment: Albumin (as Excipient) by Manufacturer
3.1 Global Albumin (as Excipient) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Albumin (as Excipient) Revenue by Manufacturer (2018-2023)
3.3 Global Albumin (as Excipient) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Albumin (as Excipient) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Albumin (as Excipient) Manufacturer Market Share in 2022
3.4.2 Top 6 Albumin (as Excipient) Manufacturer Market Share in 2022
3.5 Albumin (as Excipient) Market: Overall Company Footprint Analysis
3.5.1 Albumin (as Excipient) Market: Region Footprint
3.5.2 Albumin (as Excipient) Market: Company Product Type Footprint
3.5.3 Albumin (as Excipient) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Albumin (as Excipient) Market Size by Region
4.1.1 Global Albumin (as Excipient) Sales Quantity by Region (2018-2029)
4.1.2 Global Albumin (as Excipient) Consumption Value by Region (2018-2029)
4.1.3 Global Albumin (as Excipient) Average Price by Region (2018-2029)
4.2 North America Albumin (as Excipient) Consumption Value (2018-2029)
4.3 Europe Albumin (as Excipient) Consumption Value (2018-2029)
4.4 Asia-Pacific Albumin (as Excipient) Consumption Value (2018-2029)
4.5 South America Albumin (as Excipient) Consumption Value (2018-2029)
4.6 Middle East and Africa Albumin (as Excipient) Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Albumin (as Excipient) Sales Quantity by Type (2018-2029)
5.2 Global Albumin (as Excipient) Consumption Value by Type (2018-2029)
5.3 Global Albumin (as Excipient) Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Albumin (as Excipient) Sales Quantity by Application (2018-2029)
6.2 Global Albumin (as Excipient) Consumption Value by Application (2018-2029)
6.3 Global Albumin (as Excipient) Average Price by Application (2018-2029)
7 North America
7.1 North America Albumin (as Excipient) Sales Quantity by Type (2018-2029)
7.2 North America Albumin (as Excipient) Sales Quantity by Application (2018-2029)
7.3 North America Albumin (as Excipient) Market Size by Country
7.3.1 North America Albumin (as Excipient) Sales Quantity by Country (2018-2029)
7.3.2 North America Albumin (as Excipient) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Albumin (as Excipient) Sales Quantity by Type (2018-2029)
8.2 Europe Albumin (as Excipient) Sales Quantity by Application (2018-2029)
8.3 Europe Albumin (as Excipient) Market Size by Country
8.3.1 Europe Albumin (as Excipient) Sales Quantity by Country (2018-2029)
8.3.2 Europe Albumin (as Excipient) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Albumin (as Excipient) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Albumin (as Excipient) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Albumin (as Excipient) Market Size by Region
9.3.1 Asia-Pacific Albumin (as Excipient) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Albumin (as Excipient) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Albumin (as Excipient) Sales Quantity by Type (2018-2029)
10.2 South America Albumin (as Excipient) Sales Quantity by Application (2018-2029)
10.3 South America Albumin (as Excipient) Market Size by Country
10.3.1 South America Albumin (as Excipient) Sales Quantity by Country (2018-2029)
10.3.2 South America Albumin (as Excipient) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Albumin (as Excipient) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Albumin (as Excipient) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Albumin (as Excipient) Market Size by Country
11.3.1 Middle East & Africa Albumin (as Excipient) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Albumin (as Excipient) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Albumin (as Excipient) Market Drivers
12.2 Albumin (as Excipient) Market Restraints
12.3 Albumin (as Excipient) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Albumin (as Excipient) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Albumin (as Excipient)
13.3 Albumin (as Excipient) Production Process
13.4 Albumin (as Excipient) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Albumin (as Excipient) Typical Distributors
14.3 Albumin (as Excipient) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Albumin (as Excipient) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Albumin (as Excipient) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. CSL Basic Information, Manufacturing Base and Competitors
Table 4. CSL Major Business
Table 5. CSL Albumin (as Excipient) Product and Services
Table 6. CSL Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. CSL Recent Developments/Updates
Table 8. Grifols Basic Information, Manufacturing Base and Competitors
Table 9. Grifols Major Business
Table 10. Grifols Albumin (as Excipient) Product and Services
Table 11. Grifols Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Grifols Recent Developments/Updates
Table 13. Takeda Basic Information, Manufacturing Base and Competitors
Table 14. Takeda Major Business
Table 15. Takeda Albumin (as Excipient) Product and Services
Table 16. Takeda Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Takeda Recent Developments/Updates
Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
Table 19. Octapharma Major Business
Table 20. Octapharma Albumin (as Excipient) Product and Services
Table 21. Octapharma Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Octapharma Recent Developments/Updates
Table 23. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 24. Hualan Bio Major Business
Table 25. Hualan Bio Albumin (as Excipient) Product and Services
Table 26. Hualan Bio Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Hualan Bio Recent Developments/Updates
Table 28. CBPO Basic Information, Manufacturing Base and Competitors
Table 29. CBPO Major Business
Table 30. CBPO Albumin (as Excipient) Product and Services
Table 31. CBPO Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. CBPO Recent Developments/Updates
Table 33. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 34. Shanghai RAAS Major Business
Table 35. Shanghai RAAS Albumin (as Excipient) Product and Services
Table 36. Shanghai RAAS Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Shanghai RAAS Recent Developments/Updates
Table 38. Kedrion Basic Information, Manufacturing Base and Competitors
Table 39. Kedrion Major Business
Table 40. Kedrion Albumin (as Excipient) Product and Services
Table 41. Kedrion Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Kedrion Recent Developments/Updates
Table 43. LFB Group Basic Information, Manufacturing Base and Competitors
Table 44. LFB Group Major Business
Table 45. LFB Group Albumin (as Excipient) Product and Services
Table 46. LFB Group Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. LFB Group Recent Developments/Updates
Table 48. Albumedix Basic Information, Manufacturing Base and Competitors
Table 49. Albumedix Major Business
Table 50. Albumedix Albumin (as Excipient) Product and Services
Table 51. Albumedix Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Albumedix Recent Developments/Updates
Table 53. Biotest Basic Information, Manufacturing Base and Competitors
Table 54. Biotest Major Business
Table 55. Biotest Albumin (as Excipient) Product and Services
Table 56. Biotest Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Biotest Recent Developments/Updates
Table 58. Merck Basic Information, Manufacturing Base and Competitors
Table 59. Merck Major Business
Table 60. Merck Albumin (as Excipient) Product and Services
Table 61. Merck Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Merck Recent Developments/Updates
Table 63. Ventria (InVitria) Basic Information, Manufacturing Base and Competitors
Table 64. Ventria (InVitria) Major Business
Table 65. Ventria (InVitria) Albumin (as Excipient) Product and Services
Table 66. Ventria (InVitria) Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Ventria (InVitria) Recent Developments/Updates
Table 68. HiMedia Basic Information, Manufacturing Base and Competitors
Table 69. HiMedia Major Business
Table 70. HiMedia Albumin (as Excipient) Product and Services
Table 71. HiMedia Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. HiMedia Recent Developments/Updates
Table 73. Global Albumin (as Excipient) Sales Quantity by Manufacturer (2018-2023) & (MT)
Table 74. Global Albumin (as Excipient) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Albumin (as Excipient) Average Price by Manufacturer (2018-2023) & (USD/Kg)
Table 76. Market Position of Manufacturers in Albumin (as Excipient), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Albumin (as Excipient) Production Site of Key Manufacturer
Table 78. Albumin (as Excipient) Market: Company Product Type Footprint
Table 79. Albumin (as Excipient) Market: Company Product Application Footprint
Table 80. Albumin (as Excipient) New Market Entrants and Barriers to Market Entry
Table 81. Albumin (as Excipient) Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Albumin (as Excipient) Sales Quantity by Region (2018-2023) & (MT)
Table 83. Global Albumin (as Excipient) Sales Quantity by Region (2024-2029) & (MT)
Table 84. Global Albumin (as Excipient) Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Albumin (as Excipient) Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Albumin (as Excipient) Average Price by Region (2018-2023) & (USD/Kg)
Table 87. Global Albumin (as Excipient) Average Price by Region (2024-2029) & (USD/Kg)
Table 88. Global Albumin (as Excipient) Sales Quantity by Type (2018-2023) & (MT)
Table 89. Global Albumin (as Excipient) Sales Quantity by Type (2024-2029) & (MT)
Table 90. Global Albumin (as Excipient) Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Albumin (as Excipient) Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Albumin (as Excipient) Average Price by Type (2018-2023) & (USD/Kg)
Table 93. Global Albumin (as Excipient) Average Price by Type (2024-2029) & (USD/Kg)
Table 94. Global Albumin (as Excipient) Sales Quantity by Application (2018-2023) & (MT)
Table 95. Global Albumin (as Excipient) Sales Quantity by Application (2024-2029) & (MT)
Table 96. Global Albumin (as Excipient) Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Albumin (as Excipient) Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Albumin (as Excipient) Average Price by Application (2018-2023) & (USD/Kg)
Table 99. Global Albumin (as Excipient) Average Price by Application (2024-2029) & (USD/Kg)
Table 100. North America Albumin (as Excipient) Sales Quantity by Type (2018-2023) & (MT)
Table 101. North America Albumin (as Excipient) Sales Quantity by Type (2024-2029) & (MT)
Table 102. North America Albumin (as Excipient) Sales Quantity by Application (2018-2023) & (MT)
Table 103. North America Albumin (as Excipient) Sales Quantity by Application (2024-2029) & (MT)
Table 104. North America Albumin (as Excipient) Sales Quantity by Country (2018-2023) & (MT)
Table 105. North America Albumin (as Excipient) Sales Quantity by Country (2024-2029) & (MT)
Table 106. North America Albumin (as Excipient) Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Albumin (as Excipient) Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Albumin (as Excipient) Sales Quantity by Type (2018-2023) & (MT)
Table 109. Europe Albumin (as Excipient) Sales Quantity by Type (2024-2029) & (MT)
Table 110. Europe Albumin (as Excipient) Sales Quantity by Application (2018-2023) & (MT)
Table 111. Europe Albumin (as Excipient) Sales Quantity by Application (2024-2029) & (MT)
Table 112. Europe Albumin (as Excipient) Sales Quantity by Country (2018-2023) & (MT)
Table 113. Europe Albumin (as Excipient) Sales Quantity by Country (2024-2029) & (MT)
Table 114. Europe Albumin (as Excipient) Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Albumin (as Excipient) Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Albumin (as Excipient) Sales Quantity by Type (2018-2023) & (MT)
Table 117. Asia-Pacific Albumin (as Excipient) Sales Quantity by Type (2024-2029) & (MT)
Table 118. Asia-Pacific Albumin (as Excipient) Sales Quantity by Application (2018-2023) & (MT)
Table 119. Asia-Pacific Albumin (as Excipient) Sales Quantity by Application (2024-2029) & (MT)
Table 120. Asia-Pacific Albumin (as Excipient) Sales Quantity by Region (2018-2023) & (MT)
Table 121. Asia-Pacific Albumin (as Excipient) Sales Quantity by Region (2024-2029) & (MT)
Table 122. Asia-Pacific Albumin (as Excipient) Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Albumin (as Excipient) Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Albumin (as Excipient) Sales Quantity by Type (2018-2023) & (MT)
Table 125. South America Albumin (as Excipient) Sales Quantity by Type (2024-2029) & (MT)
Table 126. South America Albumin (as Excipient) Sales Quantity by Application (2018-2023) & (MT)
Table 127. South America Albumin (as Excipient) Sales Quantity by Application (2024-2029) & (MT)
Table 128. South America Albumin (as Excipient) Sales Quantity by Country (2018-2023) & (MT)
Table 129. South America Albumin (as Excipient) Sales Quantity by Country (2024-2029) & (MT)
Table 130. South America Albumin (as Excipient) Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Albumin (as Excipient) Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Albumin (as Excipient) Sales Quantity by Type (2018-2023) & (MT)
Table 133. Middle East & Africa Albumin (as Excipient) Sales Quantity by Type (2024-2029) & (MT)
Table 134. Middle East & Africa Albumin (as Excipient) Sales Quantity by Application (2018-2023) & (MT)
Table 135. Middle East & Africa Albumin (as Excipient) Sales Quantity by Application (2024-2029) & (MT)
Table 136. Middle East & Africa Albumin (as Excipient) Sales Quantity by Region (2018-2023) & (MT)
Table 137. Middle East & Africa Albumin (as Excipient) Sales Quantity by Region (2024-2029) & (MT)
Table 138. Middle East & Africa Albumin (as Excipient) Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Albumin (as Excipient) Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Albumin (as Excipient) Raw Material
Table 141. Key Manufacturers of Albumin (as Excipient) Raw Materials
Table 142. Albumin (as Excipient) Typical Distributors
Table 143. Albumin (as Excipient) Typical Customers
List of Figures
Figure 1. Albumin (as Excipient) Picture
Figure 2. Global Albumin (as Excipient) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Albumin (as Excipient) Consumption Value Market Share by Type in 2022
Figure 4. Human Serum Albumin Examples
Figure 5. Recombinant Albumin Examples
Figure 6. Global Albumin (as Excipient) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Albumin (as Excipient) Consumption Value Market Share by Application in 2022
Figure 8. Cell Culture Media Examples
Figure 9. Medical Supplements Examples
Figure 10. Therapeutics Examples
Figure 11. Global Albumin (as Excipient) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Albumin (as Excipient) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Albumin (as Excipient) Sales Quantity (2018-2029) & (MT)
Figure 14. Global Albumin (as Excipient) Average Price (2018-2029) & (USD/Kg)
Figure 15. Global Albumin (as Excipient) Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Albumin (as Excipient) Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Albumin (as Excipient) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Albumin (as Excipient) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Albumin (as Excipient) Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Albumin (as Excipient) Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Albumin (as Excipient) Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Albumin (as Excipient) Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Albumin (as Excipient) Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Albumin (as Excipient) Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Albumin (as Excipient) Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Albumin (as Excipient) Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Albumin (as Excipient) Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Albumin (as Excipient) Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Albumin (as Excipient) Average Price by Type (2018-2029) & (USD/Kg)
Figure 30. Global Albumin (as Excipient) Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Albumin (as Excipient) Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Albumin (as Excipient) Average Price by Application (2018-2029) & (USD/Kg)
Figure 33. North America Albumin (as Excipient) Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Albumin (as Excipient) Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Albumin (as Excipient) Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Albumin (as Excipient) Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Albumin (as Excipient) Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Albumin (as Excipient) Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Albumin (as Excipient) Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Albumin (as Excipient) Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Albumin (as Excipient) Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Albumin (as Excipient) Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Albumin (as Excipient) Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Albumin (as Excipient) Consumption Value Market Share by Region (2018-2029)
Figure 53. China Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Albumin (as Excipient) Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Albumin (as Excipient) Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Albumin (as Excipient) Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Albumin (as Excipient) Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Albumin (as Excipient) Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Albumin (as Excipient) Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Albumin (as Excipient) Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Albumin (as Excipient) Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Albumin (as Excipient) Market Drivers
Figure 74. Albumin (as Excipient) Market Restraints
Figure 75. Albumin (as Excipient) Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Albumin (as Excipient) in 2022
Figure 78. Manufacturing Process Analysis of Albumin (as Excipient)
Figure 79. Albumin (as Excipient) Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
